Publication | Closed Access
Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study
21
Citations
26
References
2021
Year
Retrospective Cohort StudyPsychiatryTreatment Resistant DepressionPsychotropic MedicationClinical TrialsDepressionTreatment OptionPharmacotherapyMood DisordersMental HealthRelapse PreventionMedicine24-Week Pramipexole AugmentationPsychopathologySide Effect
| Year | Citations | |
|---|---|---|
Page 1
Page 1